Cardiovascular Drug Delivery Epidemiology and Tota

Dublin, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Cardiovascular Drug Delivery - Technologies, Markets and Companies" to their offering. The cardiovascular drug delivery markets are estimated for the years 2015 to 2025 on the basis of epidemiology and total markets for cardiovascular therapeutics.

The estimates take into consideration the anticipated advances and availability of various technologies, particularly drug delivery devices in the future. Markets for drug-eluting stents are calculated separately. Role of drug delivery in developing cardiovascular markets is defined and unmet needs in cardiovascular drug delivery technologies are identified. Role of drug delivery in various cardiovascular disorders such as myocardial ischemia, hypertension and hypercholesterolemia is discussed. Cardioprotection is also discussed. Some of the preparations and technologies are also applicable to peripheral arterial diseases. Controlled release systems are based on chronopharmacology, which deals with the effects of circadian biological rhythms on drug actions.A full chapter is devoted to drug-eluting stents as treatment for restenosis following stenting of coronary arteries.Fifteen companies are involved in drug-eluting stents. Selected 82 companies that either develop technologies for drug delivery to the cardiovascular system or products using these technologies are profiled and 80 collaborations between companies are tabulated. The bibliography includes 200 selected references from recent literature on this topic. The report is supplemented with 30 tables and 8 figures. Key Topics Covered: Executive Summary 1. Cardiovascular Diseases 2. Methods for Drug Delivery to the Cardiovascular System 3. Cell Therapy for Cardiovascular Disorders 4. Gene Therapy for Cardiovascular Disorders 5. Drug-Eluting Stents 6. Markets for Cardiovascular Drug Delivery 7. Companies involved in Cardiovascular Drug Delivery 8. References For more information about this report visit http://www.researchandmarkets.com/research/8v...iovascular

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Drug Delivery